These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21917810)

  • 1. Adenosine receptor signaling modulates permeability of the blood-brain barrier.
    Carman AJ; Mills JH; Krenz A; Kim DG; Bynoe MS
    J Neurosci; 2011 Sep; 31(37):13272-80. PubMed ID: 21917810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine receptor signaling: a key to opening the blood-brain door.
    Bynoe MS; Viret C; Yan A; Kim DG
    Fluids Barriers CNS; 2015 Sep; 12():20. PubMed ID: 26330053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability.
    Kim DG; Bynoe MS
    Mol Neurobiol; 2015 Aug; 52(1):664-78. PubMed ID: 25262373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist.
    Gao X; Qian J; Zheng S; Changyi Y; Zhang J; Ju S; Zhu J; Li C
    ACS Nano; 2014 Apr; 8(4):3678-89. PubMed ID: 24673594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier.
    Kim DG; Bynoe MS
    J Clin Invest; 2016 May; 126(5):1717-33. PubMed ID: 27043281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Blood-Brain Barrier Permeability by Activating Adenosine A2 Receptors in Oncological Treatment.
    Wala K; Szlasa W; Saczko J; Rudno-Rudzińska J; Kulbacka J
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33923147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
    Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
    J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A1 restores Aβ
    Park JC; Baik SH; Han SH; Cho HJ; Choi H; Kim HJ; Choi H; Lee W; Kim DK; Mook-Jung I
    Aging Cell; 2017 Feb; 16(1):149-161. PubMed ID: 27633771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilobalide reversibly modulates blood-brain barrier permeability through promoting adenosine A1 receptor-mediated phosphorylation of actin-binding proteins.
    Guo C; Wang H; Liang W; Xu W; Li Y; Song L; Zhang D; Hu Y; Han B; Wang W; Yang Y; Bei W; Guo J
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1077-1084. PubMed ID: 32312522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.
    Ramirez SH; Haskó J; Skuba A; Fan S; Dykstra H; McCormick R; Reichenbach N; Krizbai I; Mahadevan A; Zhang M; Tuma R; Son YJ; Persidsky Y
    J Neurosci; 2012 Mar; 32(12):4004-16. PubMed ID: 22442067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptor agonist NECA increases cerebral extravasation of fluorescein and low molecular weight dextran independent of blood-brain barrier modulation.
    Cheng CC; Yang YL; Liao KH; Lai TW
    Sci Rep; 2016 Mar; 6():23882. PubMed ID: 27025761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
    Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
    Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba extract improves brain uptake of ginsenosides by increasing blood-brain barrier permeability via activating A1 adenosine receptor signaling pathway.
    Liang W; Xu W; Zhu J; Zhu Y; Gu Q; Li Y; Guo C; Huang Y; Yu J; Wang W; Hu Y; Zhao Y; Han B; Bei W; Guo J
    J Ethnopharmacol; 2020 Jan; 246():112243. PubMed ID: 31541722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy.
    Gustafsson S; Gustavsson T; Roshanbin S; Hultqvist G; Hammarlund-Udenaes M; Sehlin D; Syvänen S
    Neuropharmacology; 2018 Dec; 143():1-9. PubMed ID: 30201212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
    Versele R; Sevin E; Gosselet F; Fenart L; Candela P
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery.
    Oikari LE; Pandit R; Stewart R; Cuní-López C; Quek H; Sutharsan R; Rantanen LM; Oksanen M; Lehtonen S; de Boer CM; Polo JM; Götz J; Koistinaho J; White AR
    Stem Cell Reports; 2020 May; 14(5):924-939. PubMed ID: 32275861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies.
    Bien-Ly N; Boswell CA; Jeet S; Beach TG; Hoyte K; Luk W; Shihadeh V; Ulufatu S; Foreman O; Lu Y; DeVoss J; van der Brug M; Watts RJ
    Neuron; 2015 Oct; 88(2):289-97. PubMed ID: 26494278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
    Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
    J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.